These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2944152)

  • 41. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
    Marcusson J; Eriksson K
    J Neurochem; 1988 Nov; 51(5):1477-81. PubMed ID: 2971784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters.
    De Oliveira AM; Schoemaker H; Segonzac A; Langer SZ
    Neuropharmacology; 1989 Aug; 28(8):823-8. PubMed ID: 2528702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The serotonin transporter from human brain: purification and partial characterization.
    Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
    Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
    Bäckström I; Bergström M; Marcusson J
    Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo inhibition of [3H]imipramine binding by cadmium.
    Peterson LL; Bartfai T
    Eur J Pharmacol; 1983 Jun; 90(2-3):289-92. PubMed ID: 6873187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins.
    Plenge P; Mellerup ET; Nielsen M
    Eur J Pharmacol; 1990 Sep; 189(2-3):129-34. PubMed ID: 2147655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different components of 3H-imipramine binding in rat brain membranes: relation to serotonin uptake sites.
    Gobbi M; Taddei C; Mennini T
    Life Sci; 1988; 42(5):575-83. PubMed ID: 3339949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [3H]paroxetine binding in human platelets in relation to age and sex.
    Andersson A; Marcusson J
    Neurobiol Aging; 1990; 11(6):615-8. PubMed ID: 2149169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
    Moret C; Briley M
    J Neurochem; 1986 Nov; 47(5):1609-13. PubMed ID: 2944992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3H-Imipramine high-affinity binding sites in rat brain. Effects of imipramine and lithium.
    Plenge P; Mellerup ET
    Psychopharmacology (Berl); 1982; 77(1):94-7. PubMed ID: 6812124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.